December 2, 2013

Drug maker Mylan and the Elton John AIDS Foundation will donate $1 million to the Business Leadership Council for a Generation Born HIV Free, the two said.

December 2, 2013

Rite Aid has promoted Karen Staniforth, VP pharmacy for the chain's mid-Atlantic division, to group VP pharmacy initiatives and clinical services, the company said Monday.

December 2, 2013

Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

December 2, 2013

Vaccines have prevented an estimated 100 million cases of serious childhood contagious diseases in the nearly 90 years since the vaccine for pertussis, or whooping cough, became available, according to a new study.

December 2, 2013

Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

November 27, 2013

A new study is helping to provide a better understanding of vaccines for whooping cough, the Food and Drug Administration announced Wednesday.

November 26, 2013

Drug maker AbbVie is launching an international awareness campaign focused on women living with HIV, the drug maker said Tuesday.

November 26, 2013

German chemical and pharmaceutical giant Bayer plans to buy Norwegian drug maker Algeta for $2.4 billion, Algeta confirmed Tuesday.

November 26, 2013

The Food and Drug Administration has accepted Purdue Pharma's regulatory approval application for a new opioid drug, Purdue said Tuesday.

November 26, 2013

Generic drug maker Hospira will have its investor conference next week, the company said Tuesday.

November 26, 2013

The Food and Drug Administration has approved a new tablet form of an antifungal drug made by Merck, the company said Tuesday.

November 26, 2013

QRxPharma has resubmitted its regulatory approval application for an opioid painkiller for which it has sought Food and Drug Administration approval since 2011, the company said Tuesday.

November 26, 2013

The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.

November 25, 2013

The Food and Drug Administration has approved a new treatment made by Johnson & Johnson for hepatitis C, the drug maker said.

November 25, 2013

Federal regulators are lifting some restrictions on a diabetes drug that were placed two years ago after studies linked the drug to increased cardiovascular risk.

November 25, 2013

Four pharmacists from Diplomat are among the 49 across the country who have received certification from the Specialty Pharmacy Certification Board, Diplomat said Monday.

November 25, 2013

Pfizer on Monday launched Robitussin Maximum Strength Cough + Congestion DM, a new liquid-filled capsule that helps control cough on-the-go.

November 25, 2013

Executives from retail, manufacturing, regulation and others are among the four new appointees to the Pharmacy Quality Alliance's board of directors for next year, the group said Monday.

November 25, 2013

A pharmacy school in Texas has been named CVS Caremark Partner of the Year, according to published reports.

November 22, 2013

Cornerstone Therapeutics has added specialty pharmacy Diplomat to its limited-distribution network for a newly approved treatment for cystic fibrosis, Diplomat said Friday.

November 22, 2013

The Food and Drug Administration has approved a drug made by Bayer HealthCare Pharmaceuticals for treating thyroid cancer, the agency said Friday.

November 22, 2013

The Food and Drug Administration has granted regular approval to a new drug made by Pfizer for treating a form of lung cancer, the drug maker said.

November 22, 2013

Sandoz has launched an authorized generic version of a topical drug for treating actinic keratosis, the company said.

November 22, 2013

Teva Pharmaceutical Industries has launched its generic version of a drug for patients with cystic fibrosis, the Israeli drug maker said Thursday.